By: Hibah Khaja
Gossec L, Coates L, Gladman D, et al. Apremilast treatment in early oligoarticular psoriatic arthritis improves clinical and patient-reported outcomes for up to 48 weeks – data from a phase 4 trial.
Hibah Khaja is a journalist who specializes in medical and healthcare topics. She writes for a variety of publications, including The Cardiology Advisor, Psychiatry Advisor, The Clinical Advisor, Neurology Advisor, and Hematology Advisor. With a focus on evidence-based reporting, Hibah covers a wide range of subjects within the medical field, including mental health, cardiology, rheumatology, and infectious diseases.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Hibah Khaja's articles primarily focus on healthcare and pharmaceutical topics, particularly mental health, medication use, substance abuse, cardiovascular health, and rheumatoid arthritis. Her coverage frequently cites data to support the information presented in her articles.
Given this focus, Hibah would likely be interested in receiving pitches from experts or professionals with access to relevant data that supports new findings or trends within the healthcare and pharmaceutical industries. Additionally, professionals who can provide insights into emerging treatments or interventions for mental health disorders, substance abuse issues, cardiovascular diseases as well as rheumatoid arthritis may align with her coverage interests.
As there is no specified geographic focus for Hibah's articles it seems she covers a broad international perspective on these topics.
This information evolves through artificial intelligence and human feedback. Improve this profile .